Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug
Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA
Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA
The launch is yet another first of its kind innovation in India
Strive to empower public health with disinfection robotics solutions in post-pandemic era
Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
New product line to address the challenge of restrictions on use of plastic straws
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
This product will be manufactured at Lupin’s Nagpur facility in India
Subscribe To Our Newsletter & Stay Updated